Rajin K. Ahuja

BioMarck Pharmaceuticals Ltd. engages in the discovery and development of new drugs for the treatment of pulmonary diseases and disorders. It develops its lead compound, BIO-11006 Inhalation Solution, BioMarck has chosen chronic obstructive pulmonary disease (specifically chronic bronchitis) as its first target, but other diseases including asthma and cystic fibrosis are later disease targets. The company was founded by Indu Parikh, Allen F. Gant, Thomas H. Roberg and Kenneth Adl in 2002 and is headquartered in Durham, NC.

GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA.